The Times Australia
The Times World News

.
Men's Weekly

.

There’s a new COVID variant driving up infections. A virologist explains what to know about NB.1.8.1

  • Written by Lara Herrero, Associate Professor and Research Leader in Virology and Infectious Disease, Griffith University

As we enter the colder months in Australia, COVID is making headlines[1] again, this time due to the emergence of a new variant: NB.1.8.1.

Last week, the World Health Organization[2] designated NB.1.8.1 as a “variant under monitoring[3]”, owing to its growing global spread and some notable characteristics which could set it apart from earlier variants.

So what do you need to know about this new variant?

The current COVID situation

More than five years since COVID was initially declared a pandemic, we’re still experiencing regular waves of infections.

It’s more difficult to track the occurrence of the virus nowadays, as fewer people are testing and reporting infections. But available data[4] suggests in late May 2025, case numbers in Australia were ticking upwards[5].

Genomic sequencing has confirmed NB.1.8.1 is among the circulating strains[6] in Australia, and generally increasing[7]. Of cases sequenced up to May 6[8] across Australia, NB.1.8.1 ranged from less than 10% in South Australia to more than 40% in Victoria.

Wastewater surveillance in Western Australia has determined NB.1.8.1[9] is now the dominant variant in wastewater samples collected in Perth[10].

Internationally NB.1.8.1 is also growing. By late April 2025[11], it comprised roughly 10.7% of all submitted sequences – up from just 2.5% four weeks prior. While the absolute number of cases sequenced was still modest, this consistent upward trend has prompted closer monitoring by international public health agencies.

NB.1.8.1 has been spreading particularly in Asia – it was the dominant variant in Hong Kong and China[12] at the end of April.

A graphic showing the evolution of NB.1.8.1.
Lara Herrero, created using BioRender Where does this variant come from? According to the WHO, NB.1.8.1 was first detected from samples collected in January 2025[13]. It’s a sublineage of the Omicron variant, descending from the recombinant XDV lineage. “Recombinant[14]” is where a new variant arises from the genetic mixing of two or more existing variants. The image to the right shows more specifically how NB.1.8.1 came about[15]. What does the research say? Like its predecessors, NB.1.8.1 carries a suite of mutations[16] in the spike protein. This is the protein on the surface of the virus that allows it to infect us – specifically via the ACE2 receptors[17], a “doorway” to our cells. The mutations include[18] T22N, F59S, G184S, A435S, V445H, and T478I. It’s early days for this variant, so we don’t have much data on what these changes mean yet. But a recent preprint[19] (a study that has not yet been peer reviewed) offers some clues about why NB.1.8.1 may be gathering traction. Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested – suggesting it may infect cells more efficiently than earlier strains. The study also looked at how well antibodies from vaccinated or previously infected people could neutralise or “block” the variant. Results showed the neutralising response of antibodies was around 1.5 times lower to NB.1.8.1 compared to another recent variant, LP.8.1.1[20]. This means it’s possible a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants. What are the symptoms? The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. These factors could explain its rise in sequencing data. But importantly, the WHO has not yet observed any evidence it causes more severe disease[21] compared to other variants. Reports suggest symptoms of NB.1.8.1[22] should align closely with other Omicron subvariants. Common symptoms include sore throat, fatigue, fever, mild cough, muscle aches and nasal congestion. Gastrointestinal symptoms may also occur in some cases. An illustration of SARS-CoV-2, the virus that causes COVID.
COVID is continuing to evolve. Joannii/Shutterstock[23]

How about the vaccine?

There’s potential for this variant to play a significant role in Australia’s winter respiratory season. Public health responses remain focused on close monitoring, continued genomic sequencing, and promoting the uptake of updated COVID boosters.

Even if neutralising antibody levels are modestly reduced[24] against NB.1.8.1, the WHO has noted current COVID vaccines should still protect against severe disease[25] with this variant.

The most recent booster available in Australia and many other countries targets JN.1[26], from which NB.1.8.1 is descended. So it makes sense it should still offer good protection.

Ahead of winter and with a new variant on the scene, now may be a good time to consider another COVID booster if you’re eligible[27]. For some people, particularly those who are medically vulnerable, COVID can still be a serious disease.

References

  1. ^ making headlines (www.perthnow.com.au)
  2. ^ World Health Organization (cdn.who.int)
  3. ^ variant under monitoring (www.who.int)
  4. ^ available data (www.immunisationcoalition.org.au)
  5. ^ ticking upwards (www.immunisationcoalition.org.au)
  6. ^ among the circulating strains (mike-honey.github.io)
  7. ^ generally increasing (www.health.nsw.gov.au)
  8. ^ up to May 6 (mike-honey.github.io)
  9. ^ has determined NB.1.8.1 (www.health.wa.gov.au)
  10. ^ collected in Perth (www.perthnow.com.au)
  11. ^ late April 2025 (cdn.who.int)
  12. ^ Hong Kong and China (github.com)
  13. ^ collected in January 2025 (cdn.who.int)
  14. ^ Recombinant (theconversation.com)
  15. ^ came about (www.sciencedirect.com)
  16. ^ a suite of mutations (cdn.who.int)
  17. ^ ACE2 receptors (theconversation.com)
  18. ^ mutations include (cdn.who.int)
  19. ^ recent preprint (www.biorxiv.org)
  20. ^ LP.8.1.1 (theconversation.com)
  21. ^ more severe disease (cdn.who.int)
  22. ^ symptoms of NB.1.8.1 (timesofindia.indiatimes.com)
  23. ^ Joannii/Shutterstock (www.shutterstock.com)
  24. ^ are modestly reduced (www.biorxiv.org)
  25. ^ protect against severe disease (cdn.who.int)
  26. ^ targets JN.1 (theconversation.com)
  27. ^ if you’re eligible (www.health.gov.au)

Read more https://theconversation.com/theres-a-new-covid-variant-driving-up-infections-a-virologist-explains-what-to-know-about-nb-1-8-1-257552

Times Magazine

Effective Commercial Pest Control Solutions for a Safer Workplace

Keeping a workplace clean, safe, and free from pests is essential for maintaining productivity, protecting employee health, and upholding a company's reputation. Pests pose health risks, can cause structural damage, and can lead to serious legal an...

The Science Behind Reverse Osmosis and Why It Matters

What is reverse osmosis? Reverse osmosis (RO) is a water purification process that removes contaminants by forcing water through a semi-permeable membrane. This membrane allows only water molecules to pass through while blocking impurities such as...

Foodbank Queensland celebrates local hero for National Volunteer Week

Stephen Carey is a bit bananas.   He splits his time between his insurance broker business, caring for his young family, and volunteering for Foodbank Queensland one day a week. He’s even run the Bridge to Brisbane in a banana suit to raise mon...

Senior of the Year Nominations Open

The Allan Labor Government is encouraging all Victorians to recognise the valuable contributions of older members of our community by nominating them for the 2025 Victorian Senior of the Year Awards.  Minister for Ageing Ingrid Stitt today annou...

CNC Machining Meets Stage Design - Black Swan State Theatre Company & Tommotek

When artistry meets precision engineering, incredible things happen. That’s exactly what unfolded when Tommotek worked alongside the Black Swan State Theatre Company on several of their innovative stage productions. With tight deadlines and intrica...

Uniden Baby Video Monitor Review

Uniden has released another award-winning product as part of their ‘Baby Watch’ series. The BW4501 Baby Monitor is an easy to use camera for keeping eyes and ears on your little one. The camera is easy to set up and can be mounted to the wall or a...

The Times Features

International lager claims crown as Australia’s most preferred beer

Launching its inaugural ‘Brand Map of Australia’, Tracksuit reveals Corona as the nation’s most preferred beer  Sydney, Thursday, 29 May 2025 - From iconic mass-produced lager...

Off-the-Plan Sales Launched for $22 Million Ultra-Luxury Project ‘Vellora’ Set to Redefine Luxury Living in Brisbane’s St Lucia

A new standard of architectural distinction and elevated living is taking shape in one of Brisbane’s most coveted riverside suburbs, with off-the-plan sales officially launch...

House Removals Perth: What to Expect on Moving Day

Moving day hits differently when it's actually happening! Suddenly, that coffee table your first-born helped you assemble becomes precious cargo, and you're second-guessing wheth...

How to Maintain and Restock School First Aid Kits Efficiently

In Australian schools, whether it’s a busy primary school filled with energetic kids or a large secondary school with hundreds of students, there’s one thing that should always b...

Why smart investors are moving to shares

While previous generations built their wealth on cheap homes and massive capital gains, the window has closed (even despite the RBA’s recent ease of rates). Now, investors are shif...

Morning Light on the Runway — Capturing Miimi & Jiinda at AFW 2025

By Cesar Ocampo. Photo Ocampo Studio  There’s something deeply moving about photographing a runway show that feels more like ceremony than spectacle—and that’s exactly what Miimi ...